Article: Article released on major effect of nCPAP on blood pressure in patients with sleep apnea.

San Diego -- San Diego, January 13 /PRNewswire/ -- ResMed Inc. , a leading manufacturer and developer of products for the diagnosis, treatment, and management of sleep-disordered breathing (SDB), announced the release of compelling new clinical data on the effects of nasal Continuous Positive Airway Pressure (nCPAP) treatment on blood pressure reduction in patients with sleep apnea. The article appears in the current issue of "Circulation"; the study was performed by Doctor Heinrich Becker and colleagues at both the Philipps-University in Marburg, Germany and the University of Sydney, Australia.

There are now convincing published data demonstrating that sleep ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!